Jim Cramer Shares His Thoughts On Nordic American Tanker And GW Pharmaceuticals

by Craig Jones, Benzinga Staff Writer
December 9, 2016 8:16 AM | 24 seconds read |
On CNBC's "Mad Money", Jim Cramer said he wouldn't be a buyer of Nordic American Tanker Ltd NAT.

Cramer said results of clinical trials for a cannabis drug from GW Pharmaceuticals PLC- ADR GWPH look great, but he is concerned with the off-label use. He thinks that the success in clinical trials might be offset by people who are growing marijuana on their own.

Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: BiotechCNBCLong IdeasJim CramerShort IdeasTopicsMediaTrading IdeasGeneralCannabisJim CramerMad Money
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!